Travoprost Ophthalmic Solution shortage
Travoprost Ophthalmic Solution is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 22, 2026.
Viatris is permanently stopping its manufacture of travoprost ophthalmic solution (eye drops). Other makers — including the brand Travatan Z — still list this medicine as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Travoprost Ophthalmic Solution. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jul 7, 2026Currently in shortage2 of 2 products affected.
-
Jul 7, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Mylan Pharmaceuticals Inc., a Viatris Company 📞 877-446-3679 2 NDCS click to expand
| Status | NDC / product | Size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Travoprost Ophthalmic Solution — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Travoprost Ophthalmic Solution? options further down this page.
Why is Travoprost Ophthalmic Solution in shortage?
Mylan Pharmaceuticals (a Viatris company) has reported to the FDA that they are permanently stopping the manufacture of their travoprost ophthalmic solution 0.004% — both the 2.5 mL and 5 mL bottle sizes. That's why these specific products appear on the FDA shortage list.
Mylan did not share a more detailed public explanation for why they made this decision — just that manufacturing of these two products is being discontinued. It's worth knowing that this report covers only Mylan's versions of this eye drop, so it reflects their products specifically, not necessarily every manufacturer who makes travoprost.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Travoprost Ophthalmic Solution, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Travoprost Ophthalmic Solution?
Travoprost ophthalmic solution, the eye drop used to lower eye pressure, is currently on the FDA shortage list. I want to walk you through what this means so you can plan your next step calmly.
The shortage record here comes from one manufacturer, Mylan Pharmaceuticals (a Viatris company), and both of its strengths are affected: the 5 mL and the 2.5 mL both have no available source right now. Neither strength currently shows supply from this maker. The reason given is that Mylan is discontinuing its manufacture of the drug, so for this particular product the supply problem may be permanent.
Please keep in mind that this report reflects only Mylan. Travoprost 0.004% is still made by several other companies, so the medicine itself remains on the market — this is a good reason to talk with your pharmacist or prescriber soon.
Here is what I suggest, in order:
- Do not stop, skip, or change your drops on your own — keep using them as prescribed.
- Ask your pharmacy to check wholesalers and other manufacturers; the same medicine (travoprost 0.004%) is available from makers such as Novartis, Sagent, Apotex, Sandoz, Glenmark, and others, though it may not be in local stock.
- Because Mylan's version is being discontinued, ask your prescriber or pharmacist which option is right for you.
The manufacturer's contact number is listed on this page for reference; pharmacies usually handle those calls. This is general national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Travoprost Ophthalmic Solution?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Travoprost Ophthalmic Solution is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Travatan Z | TRAVOPROST .04 mg/mL | Solution/ Drops · Ophthalmic | Novartis Pharmaceuticals Corporation | 00078-0946-25 |
| Travoprost Ophthalmic Soluton | TRAVOPROST .04 mg/mL | Solution/ Drops · Ophthalmic | Sagent Pharmaceuticals | 25021-0002-02 |
| Travoprost Ophthalmic | TRAVOPROST .04 mg/mL | Solution · Ophthalmic | Micro Labs Limited | 42571-0130-21 |
| Travoprost | TRAVOPROST .04 mg/mL | Solution · Ophthalmic | Golden State Medical Supply, Inc. | 51407-0731-05 |
| Travoprost | TRAVOPROST .04 mg/mL | Solution · Ophthalmic | Apotex Corp. | 60505-0593-01 |
| Travatan Z | TRAVOPROST .04 mg/mL | Solution/ Drops · Ophthalmic | Sandoz Inc | 66758-0095-56 |
| Travoprost Ophthalmic Solution | TRAVOPROST .04 mg/mL | Solution/ Drops · Ophthalmic | GLENMARK PHARMACEUTICALS INC | 68462-0943-03 |
| Travoprost | TRAVOPROST .04 mg/mL | Solution/ Drops · Ophthalmic | Somerset Therapeutics, LLC | 70069-0586-01 |
| Travoprost Ophthalmic | TRAVOPROST .04 mg/mL | Solution · Ophthalmic | Bryant Ranch Prepack | 71335-2738-01 |
Alternative dosage forms of Travoprost
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 19 productsclick to expand
Orange Book–rated equivalents of the affected sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Travoprost Ophthalmic Solution, 0.004% .04 mg/mL | Mylan | 1 bottle | $8.260 | AT2 | Availability likely |
| Travoprost Ophthalmic Soluton .04 mg/mL | Sagent | 1 bottle | $8.260 | AT2 | Availability likely |
| Travoprost Ophthalmic Solution .04 mg/mL | GLENMARK | 1 bottle | $8.260 | AT2 | Availability likely |
| Travoprost .04 mg/mL | Somerset | 1 bottle | $8.260 | AT2 | Availability likely |
| Travoprost Ophthalmic .04 mg/mL | Micro | 5 bottles | $9.332 | AT2 | Availability likely |
| Travoprost .04 mg/mL | Apotex | 1 bottle | $9.332 | AT2 | Availability likely |
| Travoprost .04 mg/mL | Somerset | 1 bottle | $9.332 | AT2 | Availability likely |
| Travoprost Ophthalmic Solution, 0.004% .04 mg/mL | Mylan | 1 bottle | $9.332 | AT2 | Availability likely |
| Travatan Z .04 mg/mL | Novartis | 1 bottle | $86.459 | AT2 | Discontinued |
| Travatan Z .04 mg/mL | Sandoz | 1 bottle | $94.236 | AT2 | Availability likely |
| Travoprost ophthalmic solution .04 mg/mL | Alembic | 1 bottle | — | AT2 | FDA listed |
| Travoprost .04 mg/mL | Golden | 1 bottle | — | AT2 | FDA listed |
| Travoprost Ophthalmic Solution USP, 0.004% Travoprost .04 mg/mL | Alembic | 1 bottle | — | — | FDA listed |
| Travoprost ophthalmic solution .04 mg/mL | Alembic | 1 bottle | — | AT2 | FDA listed |
| Travoprost Ophthalmic Solution .04 mg/mL | Gland | 1 bottle | — | AT2 | FDA listed |
| Travoprost Ophthalmic Solution .04 mg/mL | Gland | 1 bottle | — | AT2 | FDA listed |
| Travoprost Ophthalmic .04 mg/mL | Bryant | 1 bottle | — | AT2 | FDA listed |
| Travoprost Ophthalmic .04 mg/mL | Bryant | 1 bottle | — | AT2 | FDA listed |
| Travoprost Ophthalmic .04 mg/mL | Bryant | 1 bottle | — | AT2 | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Travoprost Ophthalmic Solution — that fall in the same broad treatment class (miotics and other intraocular pressure reducers) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other ophthalmology shortages
Travoprost Ophthalmic Solution shortage FAQs
Is Travoprost Ophthalmic Solution in shortage?
Which products are affected?
When will Travoprost Ophthalmic Solution be available again?
Can I still get Travoprost somewhere?
What should I do if I take Travoprost Ophthalmic Solution?
Still have a question about the Travoprost Ophthalmic Solution shortage?
Ask a pharmacist about this shortage →View Travoprost Ophthalmic Solution on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.